Stryker saw year-over-year revenue growth in the first quarter of 2025, according to financial results posted May 2.
Six things to know:
1. Quarterly revenue reached $5.9 billion, an 11.9% increase year over year.
2. Orthopedic sales grew 9.7% year over year to $2.3 billion, and med-surg and neurotechnology sales grew 13.4% to $3.5 billion.
3. Hip sales increased 12.7% year over year to $443 million, and knees grew 8.7% to $639 million.
4. Spine implant sales dipped 2.9% to $166 million.
5. Stryker operated with net earnings of $654 million. That’s a decrease of 17% year over year.
6. Stryker expects its full year 2025 revenue to grow 8.5% to 9.5% year over year.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
